Interaction Guide · Research summary

Can I take Humulus Lupulus with Temazepam?

Review Humulus Lupulus with Temazepam: possible adverse effects, preparation details, evidence limits, and sources.

Prepared by Dr. Edward M.Kim, PharmD · Clinical Director, SupplementSafety editorial team

Research summary published · Prepared · Editorial update

The short answer

Review hops before adding it to temazepam. Some preparations may affect alertness, but an exact combination study has not established the amount of added sedation.

What this answer covers

Oral Humulus lupulus female inflorescence preparations; other parts and mixed products are not assumed equivalent.

Supplement or preparation
Humulus lupulus
Medication ingredient
temazepam

What the monograph says

Hops guidance describes traditional sleep-aid use and possible driving impairment, while listing no reported interactions.

What human evidence adds

A standardized hops product caused no clinically relevant CYP probe interaction in a small study. That measured metabolism with other drugs, not sedation with temazepam.

Identify the actual product

Check that the product contains the studied plant part and list any added herbs. A tea, concentrated extract and mixed sleep product may differ. No protective timing gap is established for hops and temazepam.

Protect your alertness

Temazepam can impair coordination and alertness. Avoid driving when affected. Seek urgent help for severe difficulty waking or breathing, and tell the prescriber about all other sedating medicines and alcohol.

Evidence and practical considerations

Side effects & toxicity

Preparation-specific alertness caution is reasonable; the broad exact-pair sedation claim remains insufficient.

Exact scope
Oral Humulus lupulus female inflorescence preparations; other parts and mixed products are not assumed equivalent. with Exact oral temazepam; no blanket benzodiazepine metabolic or route transfer.
Medication form and route
oral; other cannabis routes only if explicitly discussed
Timing or duration
Exact duration and dose depend on source; single-dose and chronic use are distinguished.

What remains uncertain

  • No exact temazepam co-use trial; traditional sleep-aid use and separate-product studies do not prove additive CNS depression.

Factors that may matter: preparation and plant part; dose; other medicines; baseline alertness; clinical indication.

Research conclusion: insufficient evidence · Evidence assessment: low

Read the supporting source summaries

Source 1: current product label

dailymed.nlm.nih.gov · Source check Sep 10, 2026

Population: Patients prescribed oral temazepam.

CNS depression, impaired coordination and alertness can occur; concomitant CNS depressants require caution. Dependence and withdrawal risks require individualized tapering rather than abrupt cessation. Metabolized primarily through conjugation with no active metabolites; not an alprazolam CYP3A profile. Complex sleep behaviors can occur and CNS depressants may increase their risk.

How this applies: Exact RxNorm ingredient and oral formulation confirmed in original label; use exact indication and metabolic boundaries.

Does not quantify the requested botanical interaction risks, prove every herb is sedating, or establish a protective supplement interval.

Source 2: official herbal monograph

ema.europa.eu · Source check Sep 10, 2026

Population: Users of specified oral herbal preparations.

Traditional use for mild stress and aiding sleep; may impair driving. No interactions reported.

How this applies: Supports preparation-specific caution; does not establish additive sedation with the requested drug.

Traditional use is not proof of exact drug interaction. Part/extract boundaries and absence of clinical co-use data remain.

Source 3: original human study

pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026

Population: Sixteen peri/postmenopausal women.

No clinically relevant CYP probe interaction; alprazolam AUC declined slightly rather than showing inhibition.

How this applies: Apply only to exact medication, preparation and study exposure; comparator treatment is not co-use.

Other medications and metabolic endpoints, not temazepam/oxazepam or additive sedation; absence of PK interaction is not absence of impairment.

Research assessment: · Open full citations ↗

Review and change history

Publication status
Published research summary
Clinical review
Not yet recorded
DateUpdate
Article prepared
Current exact claims adjudicated against captured originals and explicit comparator/co-use boundaries.
Research summary published

Article revision: d384daabe190e09a

This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.

Full citations require verification. Reading this answer and the source summaries does not.

Taking other supplements or medications?

Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.

Open the interaction checker

Information, not medical advice. Do not change prescribed treatment based on this guide.